ENST00000454569.6:c.2490C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The ENST00000454569.6(SCN9A):​c.2490C>T​(p.Asn830Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000799 in 1,608,722 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0043 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00043 ( 6 hom. )

Consequence

SCN9A
ENST00000454569.6 synonymous

Scores

3
Splicing: ADA: 0.00002753
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.31

Publications

0 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000454569.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-166278134-G-A is Benign according to our data. Variant chr2-166278134-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 331980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.31 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00434 (660/152096) while in subpopulation AFR AF = 0.0151 (628/41506). AF 95% confidence interval is 0.0142. There are 5 homozygotes in GnomAd4. There are 315 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000454569.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN9A
NM_001365536.1
MANE Select
c.2517+6C>T
splice_region intron
N/ANP_001352465.1Q15858-1
SCN9A
NM_002977.4
c.2484+6C>T
splice_region intron
N/ANP_002968.2Q15858-3
SCN1A-AS1
NR_110260.1
n.1029+887G>A
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN9A
ENST00000454569.6
TSL:1
c.2490C>Tp.Asn830Asn
synonymous
Exon 15 of 15ENSP00000413212.2A0A0C4DG82
SCN9A
ENST00000642356.2
MANE Select
c.2517+6C>T
splice_region intron
N/AENSP00000495601.1Q15858-1
SCN9A
ENST00000303354.11
TSL:5
c.2517+6C>T
splice_region intron
N/AENSP00000304748.7Q15858-1

Frequencies

GnomAD3 genomes
AF:
0.00431
AC:
655
AN:
151978
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0151
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00171
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000995
AC:
244
AN:
245316
AF XY:
0.000736
show subpopulations
Gnomad AFR exome
AF:
0.0142
Gnomad AMR exome
AF:
0.000564
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000843
GnomAD4 exome
AF:
0.000430
AC:
626
AN:
1456626
Hom.:
6
Cov.:
30
AF XY:
0.000380
AC XY:
275
AN XY:
724548
show subpopulations
African (AFR)
AF:
0.0157
AC:
522
AN:
33290
American (AMR)
AF:
0.000655
AC:
29
AN:
44280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26072
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39512
South Asian (SAS)
AF:
0.0000585
AC:
5
AN:
85444
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52502
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5752
European-Non Finnish (NFE)
AF:
0.00000451
AC:
5
AN:
1109530
Other (OTH)
AF:
0.00103
AC:
62
AN:
60244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
29
58
88
117
146
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00434
AC:
660
AN:
152096
Hom.:
5
Cov.:
32
AF XY:
0.00424
AC XY:
315
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.0151
AC:
628
AN:
41506
American (AMR)
AF:
0.00170
AC:
26
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67988
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
30
60
90
120
150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00136
Hom.:
0
Bravo
AF:
0.00475
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
Channelopathy-associated congenital insensitivity to pain, autosomal recessive (1)
-
-
1
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A (1)
-
-
1
Paroxysmal extreme pain disorder (1)
-
-
1
Primary erythromelalgia (1)
-
-
1
Primary erythromelalgia;C1833661:Paroxysmal extreme pain disorder;C1855739:Channelopathy-associated congenital insensitivity to pain, autosomal recessive;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A (1)
-
-
1
SCN9A-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
15
DANN
Benign
0.67
PhyloP100
1.3
PromoterAI
0.00090
Neutral
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000028
dbscSNV1_RF
Benign
0.012
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs145316463;
hg19: chr2-167134644;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.